vidarabine has been researched along with Cell Transformation, Viral in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chamo, M; Gazit, R; Goldstein, O; Ilic, S; Keinan, N; Scharff, Y | 1 |
| Aractingi, S; Auffret, N; Bodemer, C; Brousse, N; Duong, T; Fraitag, S; Grange, F; Hermine, O | 1 |
| Fong, D; Gastl, G; Kaiser, A; Spizzo, G; Tzankov, A | 1 |
| Arcaini, L; Astori, C; Baldanti, F; Bernasconi, C; Furione, M; Gerna, G; Lazzarino, M; Orlandi, E; Pagnucco, G; Paulli, M; Viglio, A | 1 |
| Mak, TW; Wan, CW | 1 |
| Drach, JC; Shipman, C | 1 |
| Henderson, EE; Long, WK; Ribecky, R | 1 |
1 review(s) available for vidarabine and Cell Transformation, Viral
| Article | Year |
|---|---|
Cutaneous Richter's syndrome, prognosis, and clinical, histological and immunohistological patterns: report of four cases and review of the literature.
Topics: Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD5 Antigens; Cell Transformation, Viral; Epstein-Barr Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Ki-1 Antigen; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; Skin Neoplasms; Vidarabine | 2010 |
6 other study(ies) available for vidarabine and Cell Transformation, Viral
| Article | Year |
|---|---|
Syngeneic leukemia models using lentiviral transgenics.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Viral; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Immunocompetence; Lentivirus; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Oncogenes; Transplantation, Isogeneic; Vidarabine | 2021 |
Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Topics: Antineoplastic Agents; Cell Transformation, Viral; Clone Cells; Drug Resistance, Neoplasm; Epstein-Barr Virus Infections; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Hodgkin Disease; Humans; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Micromanipulation; Middle Aged; Reed-Sternberg Cells; Vidarabine | 2005 |
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Viral; Cyclophosphamide; Dexamethasone; Epstein-Barr Virus Infections; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Opportunistic Infections; Vidarabine; Virus Activation | 1999 |
Inhibition of murine sarcoma virus-induced foci formation by cytidine analogues and other drugs chemotherapeutically effective in human malignancies.
Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Line; Cell Survival; Cell Transformation, Viral; Dose-Response Relationship, Drug; Rats; Sarcoma Viruses, Murine; Vidarabine | 1979 |
Absence of adenosine deaminase activity in a mammalian cell line transformed by Rous sarcoma virus.
Topics: Adenosine; Adenosine Deaminase; Avian Sarcoma Viruses; Cell Line; Cell Transformation, Viral; Nucleoside Deaminases; Substrate Specificity; Vidarabine | 1978 |
Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.
Topics: Cell Transformation, Viral; DNA; Female; Fetal Blood; Herpesvirus 4, Human; Humans; Idoxuridine; Leukocytes; Vidarabine | 1979 |